Cargando…

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer

The degree of intrinsic and interpatient phenotypic heterogeneity and its role in tumour evolution is poorly understood. Phenotypic drifts can be transmitted via inheritable transcriptional programs. Cell-type specific transcription is maintained through the activation of epigenetically-defined regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patten, Darren K., Corleone, Giacomo, Győrffy, Balázs, Perone, Ylenia, Slaven, Neil, Barozzi, Iros, Erdős, Edina, Saiakhova, Alina, Goddard, Kate, Vingiani, Andrea, Shousha, Sami, Pongor, Lőrinc Sándor, Hadjiminas, Dimitri J., Schiavon, Gaia, Barry, Peter, Palmieri, Carlo, Coombes, Raul C., Scacheri, Peter, Pruneri, Giancarlo, Magnani, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130800/ https://www.ncbi.nlm.nih.gov/pubmed/30038216 http://dx.doi.org/10.1038/s41591-018-0091-x

Ejemplares similares

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
por: Hong, Sung Pil, et al.
Publicado: (2019)

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
por: Magnani, Luca, et al.
Publicado: (2017)

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
por: Menyhárt, Otília, et al.
Publicado: (2019)

DMXL2 drives epithelial to mesenchymal transition in hormonal therapy resistant breast cancer through notch hyper-activation
por: Faronato, Monica, et al.
Publicado: (2015)

A snapshot of 3649 Web-based services published between 1994 and 2017 shows a decrease in availability after 2 years
por: Ősz, Ágnes, et al.
Publicado: (2017)

Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
por: Pongor, Lőrinc S., et al.
Publicado: (2020)

Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2015)

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2019)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Cell Dispersal Influences Tumor Heterogeneity and Introduces a Bias in NGS Data Interpretation
por: Pongor, Lőrinc, et al.
Publicado: (2017)

A genome-wide approach to link genotype to clinical outcome by utilizing next generation sequencing and gene chip data of 6,697 breast cancer patients
por: Pongor, Lőrinc, et al.
Publicado: (2015)

Uncovering Potential Therapeutic Targets in Colorectal Cancer by Deciphering Mutational Status and Expression of Druggable Oncogenes
por: Menyhart, Otília, et al.
Publicado: (2019)

NR2F2 Orphan Nuclear Receptor is Involved in Estrogen Receptor Alpha-Mediated Transcriptional Regulation in Luminal A Breast Cancer Cells
por: Erdős, Edina, et al.
Publicado: (2020)

Integrative genomic analysis of human ribosomal DNA
por: Zentner, Gabriel E., et al.
Publicado: (2011)

An integrative bioinformatics approach reveals coding and non-coding gene variants associated with gene expression profiles and outcome in breast cancer molecular subtypes
por: Győrffy, Balázs, et al.
Publicado: (2018)

TP53 mutation hits energy metabolism and increases glycolysis in breast cancer
por: Harami-Papp, Hajnalka, et al.
Publicado: (2016)

HeurAA: Accurate and Fast Detection of Genetic Variations with a Novel Heuristic Amplicon Aligner Program for Next Generation Sequencing
por: Pongor, Lőrinc S., et al.
Publicado: (2013)

Fast and Sensitive Alignment of Microbial Whole Genome Sequencing Reads to Large Sequence Datasets on a Desktop PC: Application to Metagenomic Datasets and Pathogen Identification
por: Pongor, Lőrinc S., et al.
Publicado: (2014)

Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer
por: Pálinkás, Hajnalka Laura, et al.
Publicado: (2022)

Comparative evaluation of DNase-seq footprint identification strategies
por: Barozzi, Iros, et al.
Publicado: (2014)

Corrigendum: Comparative evaluation of DNase-seq footprint identification strategies
por: Barozzi, Iros, et al.
Publicado: (2014)

Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer
por: Bellanger, Aurélie, et al.
Publicado: (2021)

PRC2 Is Dispensable in Vivo for β-Catenin-Mediated Repression of Chondrogenesis in the Mouse Embryonic Cranial Mesenchyme
por: Ferguson, James, et al.
Publicado: (2017)

Fish the ChIPs: a pipeline for automated genomic annotation of ChIP-Seq data
por: Barozzi, Iros, et al.
Publicado: (2011)

Colon Cancer-Upregulated Long Non-Coding RNA lincDUSP Regulates Cell Cycle Genes and Potentiates Resistance to Apoptosis
por: Forrest, Megan E., et al.
Publicado: (2018)

Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits
por: Corradin, Olivia, et al.
Publicado: (2014)

Different mutations in SARS-CoV-2 associate with severe and mild outcome
por: Nagy, Ádám, et al.
Publicado: (2021)

Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells
por: Vella, Pietro, et al.
Publicado: (2012)

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis
por: Jiang, Tingting, et al.
Publicado: (2016)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Thrombopoietin signaling to chromatin elicits rapid and pervasive epigenome remodeling within poised chromatin architectures
por: Comoglio, Federico, et al.
Publicado: (2018)

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications
por: Zattarin, Emma, et al.
Publicado: (2020)

The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer
por: Magnani, Luca, et al.
Publicado: (2015)

A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results
por: Ligeti, Balázs, et al.
Publicado: (2015)

COVIDOUTCOME—estimating COVID severity based on mutation signatures in the SARS-CoV-2 genome
por: Nagy, Ádám, et al.
Publicado: (2021)

Dissection of acute stimulus-inducible nucleosome remodeling in mammalian cells
por: Comoglio, Federico, et al.
Publicado: (2019)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Cannot write session to /tmp/vufind_sessions/sess_4agr7hbat5prnmmp3iai2srlja